Jump to the Navigation Menu
Login to My AlzForum
Jump to the Search form

Papers

268093 Results

Sort By:

Publication Date
Journal Title
First Author
Most Commented

Go to another page:

34
35
36
37
38
... 17873

Send results to Selected: 0 Clear selection

Zheng N, Cao RL, Liu DY, Liu P, Zhao XY, Zhang SX, Huang M, Zheng ZH, Chen GL, Zou LB. OAB-14 alleviates mitochondrial impairment through the SIRT3-dependent mechanism in APP/PS1 transgenic mice and N2a/APP cells. Free Radic Biol Med. 2025 Jan 8; Epub 2025 Jan 8 PubMed.

Chaplygina A, Zhdanova D. Mitochondrial Fragmentation as a Key Driver of Neurodegenerative Disease. Curr Alzheimer Res. 2025 Jan 8; Epub 2025 Jan 8 PubMed.

Dykstra MM, Weskamp K, Gómez NB, Waksmacki J, Tank E, Glineburg MR, Snyder A, Pinarbasi E, Bekier M, Li X, Miller MR, Bai J, Shahzad S, Nedumaran N, Wieland C, Stewart C, Willey S, Grotewold N, McBride J, Moran JJ, Suryakumar AV, Lucas M, Tessier PM, Ward M, Todd PK, Barmada SJ. TDP43 autoregulation gives rise to dominant negative isoforms that are tightly controlled by transcriptional and post-translational mechanisms. Cell Rep. 2025 Jan 8;44(1):115113. Epub 2025 Jan 8 PubMed.

Chen H, Chang X, Zhou J, Zhang G, Cheng J, Zhang Z, Xing J, Yan C, Liu Z. Anti-neuroinflammatory and Neuroprotective Effects of T-006 on Alzheimer's Disease Models by Modulating TLR4-Mediated MyD88/ NF-κB Signaling. CNS Neurol Disord Drug Targets. 2025 Jan 8; Epub 2025 Jan 8 PubMed.

Liao J, Jiang L, Qin Y, Hu J, Tang Z. Causal Association Between Cerebrospinal Fluid Metabolites and Parkinson's Disease: A Two-Sample Bidirectional Mendelian Randomization Study. Behav Brain Res. 2025 Jan 8;:115426. Epub 2025 Jan 8 PubMed.

Li X, Ding Q, Wan X, Wu Q, Ye S, Lou Y. Fecal microbiota transplantation attenuates Alzheimer's disease symptoms in APP/PS1 transgenic mice via inhibition of the TLR4-MyD88-NF-κB signaling pathway-mediated inflammation. Behav Brain Funct. 2025 Jan 8;21(1):2. PubMed.

Watanabe M, Okochi R, Tezuka T, Ito D. Spontaneous haemorrhage in subdural hygroma in an Alzheimer's patient on lecanemab. BMJ Case Rep. 2025 Jan 8;18(1) PubMed.

Sellimi A, Panteleienko L, Mallon D, Fandler-Höfler S, Oliver R, Harvey V, Zandi MS, Banerjee G, Werring DJ. Inflammation in Cerebral Amyloid Angiopathy-Related Transient Focal Neurological Episodes. Ann Neurol. 2025 Jan 8; Epub 2025 Jan 8 PubMed.

Xing X, Zhang X, Wang K, Wang Z, Feng Y, Li X, Hua Y, Zhang L, Dong X. Post-marketing safety concerns with lecanemab: a pharmacovigilance study based on the FDA Adverse Event Reporting System database. Alzheimers Res Ther. 2025 Jan 8;17(1):15. PubMed.

Cummings JL, Atri A, Feldman HH, Hansson O, Sano M, Knop FK, Johannsen P, León T, Scheltens P. evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease. Alzheimers Res Ther. 2025 Jan 8;17(1):14. PubMed.

Zamani J, Vahid A, Avelar-Pereira B, Gozdas E, Hosseini SM, Alzheimer's Disease Neuroimaging Initiative. Mapping amyloid beta predictors of entorhinal tau in preclinical Alzheimer's disease. Alzheimers Dement. 2025 Jan 8; Epub 2025 Jan 8 PubMed.

Wyatt-Johnson SK, Ackley S, Warren J, Priya R, Wan J, Liu S, Brutkiewicz RR. The MR1/MAIT cell axis enhances dystrophic neurite development in Alzheimer's disease. Alzheimers Dement. 2025 Jan 8;:e14480. Epub 2025 Jan 8 PubMed.

Rabinovici GD, Knopman DS, Arbizu J, Benzinger TL, Donohoe KJ, Hansson O, Herscovitch P, Kuo PH, Lingler JH, Minoshima S, Murray ME, Price JC, Salloway SP, Weber CJ, Carrillo MC, Johnson KA. Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup. Alzheimers Dement. 2025 Jan 8; Epub 2025 Jan 8 PubMed.

Huang KL, Hsiao IT, Huang CW, Huang CG, Chang HI, Huang SH, Lin KJ, Ma MC, Huang CC, Chang CC. The Taiwan-ADNI workflow toward integrating plasma p-tau217 into prediction models for the risk of Alzheimer's disease and tau burden. Alzheimers Dement. 2025 Jan 8; Epub 2025 Jan 8 PubMed.

Gonay V, Dunne MP, Caceres-Delpiano J, Kajava AV. Developing machine-learning-based amyloidogenicity predictors with Cross-Beta DB. Alzheimers Dement. 2025 Jan 8; Epub 2025 Jan 8 PubMed.

Go to another page:

34
35
36
37
38
... 17873

Current Filters

No filters selected

Filter By

Papers of the Week

Current Week (316)
3-9 Jan 2025 (386)
27 Dec 2024 - 2 Jan 2025 (219)
20-26 Dec 2024 (293)

Type ?

Milestone (286)
Alzforum Recommends (3829)

Publication Range

From
1. Month
2. Year
To
1. Month
2. Year

Background
Methods
FAQ

Enter your keywords

LOGIN
HOME
About Us
Newsletter

NEWS
- All News
- Conference Coverage
WEBINARS
- All Webinars
Databases
- AlzAntibodies
- AlzBiomarker
- AlzPedia
- AlzRisk
- Brain Banks
- Genetics
  - AlzGene
  - HEX
  - Mutations
- Protocols
- Research Models
- Therapeutics
PAPERS
PROFESSIONAL RESOURCES
ABOUT AD
MY ALZFORUM

Back to the Top

Terms of Service
How to Cite
Privacy Policy
Site Map
Contact Us